Search results
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [2] [33] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
FDA Office of Media Affairs. 301-796-4540. Consumer: 888-INFO-FDA. FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as ...
Aug 28, 2024 · Pfizer-BioNTech COVID-19 Vaccine is indicated for individuals 5 through 11 years of age (via a 10mcg / 0.3mL single-dose vial presentation) and for individuals 6 months through 4 years of age (via a 3mcg / 0.3mL multi-dose vial (3 doses per vial) presentation).
Aug 30, 2021 · Other names considered for Pfizer and BioNTech's covid-19 vaccine include Covuity, RnaxCovi, Kovimerna, and RNXtract, which were filed with the U.S. Patent and Trademark Office, NPR reports.
Aug 24, 2021 · Comirnaty, as it's known, is the official, brand name for Pfizer and BioNTech's COVID-19 vaccine. The Food and Drug Administration this week gave full approval to the vaccine for people 16 and...
Jun 3, 2022 · This vaccine resource provides key vaccine-specific information for the Pfizer-BioNTech COVID-19 Vaccine Comirnaty®, a messenger RNA (mRNA) based vaccine against coronavirus disease (COVID-19).
This Vaccine Information Fact Sheet for Recipients and Caregivers comprises the Fact Sheet for the authorized Pfizer-BioNTech COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, and also includes information about the U.S. Food and Drug Administration (FDA)-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA) for use in individu...
